Savara
SVRA
#6203
Rank
NZ$1.81 B
Marketcap
NZ$8.84
Share price
-1.81%
Change (1 day)
24.34%
Change (1 year)

Earnings for Savara (SVRA)

Earnings in 2026 (TTM): -NZ$0.25 Billion

According to Savara's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -NZ$0.22 Billion a decrease over its 2024 earnings that were of -NZ$0.18 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Savara from 2002 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -NZ$0.25 Billion14.39%
2025 -NZ$0.22 Billion23.94%
2024 -NZ$0.18 Billion75.29%
2023 -NZ$97.5 Million43.38%
2022 -NZ$68.01 Million-11.31%
2021 -NZ$76.68 Million-13.3%
2020 -NZ$88.44 Million-36.53%
2019 -NZ$0.14 Billion13.76%
2018 -NZ$0.13 Billion105.54%
2017 -NZ$59.6 Million34.11%
2016 -NZ$44.44 Million-37.43%
2015 -NZ$71.02 Million38.81%
2014 -NZ$51.17 Million33.62%
2013 -NZ$38.29 Million38.49%
2012 -NZ$27.65 Million24.59%
2011 -NZ$22.2 Million-36.5%
2010 -NZ$34.95 Million-3.14%
2009 -NZ$36.08 Million-23.28%
2008 -NZ$47.03 Million8.52%
2007 -NZ$43.34 Million-34.14%
2006 -NZ$65.81 Million184.43%
2005 -NZ$23.14 Million90.75%
2004 -NZ$12.13 Million190.35%
2003 -NZ$4.18 Million11.64%
2002 -NZ$3.75 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
OPKO Health
OPK
-NZ$0.15 Billion-42.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
-NZ$32.37 Million-86.97%๐Ÿ‡บ๐Ÿ‡ธ USA